{"transactions":[{"id":1985084,"issuer":{"id":11337,"kind":"organization","name":"NEW AMERICA HIGH INCOME FUND INC","symbol":"HYB"},"owners":[{"id":116280,"kind":"person","name":"Bower Joseph L.","position":1,"cik":"0001227947","reported_name":"Bower Joseph L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-01T14:53:20.000Z","date":"2023-02-27","kind":"purchase","acquired":true,"shares":2000,"price":6.8099,"value":13619.8,"ownership":{"direct":true},"balance_after":9111,"source":{"system":"sec-edgar","filing":"0001255647-23-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/825345/000125564723000001/primary_doc.xml","form_type":"4"}},{"id":3244743,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":116280,"kind":"person","name":"Bower Joseph L.","position":1,"cik":"0001227947","reported_name":"Bower Joseph L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-27T23:50:16.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":4107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These deferred stock units vest in full on February 25, 2021. Once vested, the settlement of these deferred stock units shall be deferred until the grantee incurs a \"separation of service\" as that term is defined in Section 409A of the internal revenue code, at which time the deferred stock units shall be settled in five equal annual installments each occurring within 60 days of the anniversary of such event."}],"balance_after":17117,"source":{"system":"sec-edgar","filing":"0001171843-20-001359","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184320001359/ownership.xml","form_type":"4"}},{"id":3356836,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":116280,"kind":"person","name":"Bower Joseph L.","position":1,"cik":"0001227947","reported_name":"Bower Joseph L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-29T21:06:27.000Z","date":"2019-11-27","kind":"gift","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock of Anika Therapeutics, Inc. were given by Dr. Bower as a bona fide gift to the President and Fellows of Harvard College, a 501(c)(3) non-profit organization, for no valuable consideration on November 27, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock of Anika Therapeutics, Inc. were given by Dr. Bower as a bona fide gift to the President and Fellows of Harvard College, a 501(c)(3) non-profit organization, for no valuable consideration on November 27, 2019."}],"balance_after":13010,"source":{"system":"sec-edgar","filing":"0001171843-19-007869","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319007869/ownership.xml","form_type":"4"}},{"id":3431502,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":116280,"kind":"person","name":"Bower Joseph L.","position":1,"cik":"0001227947","reported_name":"Bower Joseph L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-22T20:05:24.000Z","date":"2019-08-20","kind":"sale","acquired":false,"shares":1994,"price":55.57,"value":110806.58,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sales price. The shares were sold on 8/20/19 at prices ranging from $55.50 to $55.66 per share. Full information regarding the number of shares sold at each price shall be provided to the Staff, Issuer or any security holder, upon request."}],"balance_after":43010,"source":{"system":"sec-edgar","filing":"0001171843-19-005617","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319005617/ownership.xml","form_type":"4"}},{"id":3627454,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":116280,"kind":"person","name":"Bower Joseph L.","position":1,"cik":"0001227947","reported_name":"BOWER JOSEPH I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-28T21:31:38.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":3842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on February 26, 2020."}],"balance_after":45004,"source":{"system":"sec-edgar","filing":"0001171843-19-001384","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319001384/ownership.xml","form_type":"4"}},{"id":4088830,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":116280,"kind":"person","name":"Bower Joseph L.","position":1,"cik":"0001227947","reported_name":"BOWER JOSEPH I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-26T21:06:01.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":1626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on January 24, 2019."}],"balance_after":41162,"source":{"system":"sec-edgar","filing":"0001171843-18-000688","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184318000688/formfour.xml","form_type":"4"}},{"id":4475939,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":116280,"kind":"person","name":"Bower Joseph L.","position":1,"cik":"0001227947","reported_name":"BOWER JOSEPH I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-31T21:07:00.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":1994,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on January 27, 2018."}],"balance_after":39536,"source":{"system":"sec-edgar","filing":"0001171843-17-000585","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317000585/formfour.xml","form_type":"4"}},{"id":4562865,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":116280,"kind":"person","name":"Bower Joseph L.","position":1,"cik":"0001227947","reported_name":"BOWER JOSEPH I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Appreciation Right","published_at":"2016-11-10T00:05:37.000Z","date":"2016-11-07","kind":"exercise","acquired":false,"shares":1540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Exercise of stock appreciation rights (\"SARs\") granted on December 14, 2006, which vested in full immediately on such date, and expiring on December 14, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercise of stock appreciation rights (\"SARs\") granted on December 14, 2006, which vested in full immediately on such date, and expiring on December 14, 2016."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Exercise of stock appreciation rights (\"SARs\") granted on December 14, 2006, which vested in full immediately on such date, and expiring on December 14, 2016."}],"balance_after":0,"derivative":{"exercise_price":12.36,"underlying":"Common Stock","underlying_shares":1540},"source":{"system":"sec-edgar","filing":"0001171843-16-013102","document":"f4_bower110916.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184316013102/f4_bower110916.xml","form_type":"4"}},{"id":4562864,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":116280,"kind":"person","name":"Bower Joseph L.","position":1,"cik":"0001227947","reported_name":"BOWER JOSEPH I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-10T00:05:37.000Z","date":"2016-11-09","kind":"sale","acquired":false,"shares":40,"price":43.31,"value":1732.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Reflects an aggregate of 540 shares of common stock sold to satisfy tax obligations related to the exercise of the above listed SARs award by the Reporting Person on November 9, 2016."}],"balance_after":37542,"source":{"system":"sec-edgar","filing":"0001171843-16-013102","document":"f4_bower110916.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184316013102/f4_bower110916.xml","form_type":"4"}},{"id":4562863,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":116280,"kind":"person","name":"Bower Joseph L.","position":1,"cik":"0001227947","reported_name":"BOWER JOSEPH I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-10T00:05:37.000Z","date":"2016-11-09","kind":"sale","acquired":false,"shares":500,"price":43.4,"value":21700.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Reflects an aggregate of 540 shares of common stock sold to satisfy tax obligations related to the exercise of the above listed SARs award by the Reporting Person on November 9, 2016."}],"balance_after":37582,"source":{"system":"sec-edgar","filing":"0001171843-16-013102","document":"f4_bower110916.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184316013102/f4_bower110916.xml","form_type":"4"}},{"id":4562862,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":116280,"kind":"person","name":"Bower Joseph L.","position":1,"cik":"0001227947","reported_name":"BOWER JOSEPH I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-10T00:05:37.000Z","date":"2016-11-07","kind":"tax_withholding","acquired":false,"shares":431,"price":44.26,"value":19076.06,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Reflects 431 shares of common stock utilized to cover the exercise price of the above listed SARs award by the Reporting Person on November 7, 2016."}],"balance_after":38082,"source":{"system":"sec-edgar","filing":"0001171843-16-013102","document":"f4_bower110916.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184316013102/f4_bower110916.xml","form_type":"4"}},{"id":4562861,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":116280,"kind":"person","name":"Bower Joseph L.","position":1,"cik":"0001227947","reported_name":"BOWER JOSEPH I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-10T00:05:37.000Z","date":"2016-11-07","kind":"exercise","acquired":true,"shares":1540,"price":12.36,"value":19034.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Exercise of stock appreciation rights (\"SARs\") granted on December 14, 2006, which vested in full immediately on such date, and expiring on December 14, 2016."}],"balance_after":38513,"source":{"system":"sec-edgar","filing":"0001171843-16-013102","document":"f4_bower110916.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184316013102/f4_bower110916.xml","form_type":"4"}}]}